Search research articles
Contact Us
Filters
Showing results (141-150 of 313) with videos related to
Page
of 32
Sort By:
European Journal of Haematology
|
July 9, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Microorganisms
|
January 6, 2021
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients
Camilla Bitossi, Federica Frasca, Agnese Viscido, et al.
British Journal of Haematology
|
March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology
|
April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Leukemia & Lymphoma
|
August 23, 2008
The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods
Eugenio Lucia, Bruno Martino, Corrado Mammi, et al.
Pathogens (Basel, Switzerland)
|
February 23, 2024
The Epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative Women and Men: A Ten-Year Retrospective Observational Study in Rome (Italy)
Matteo Fracella, Giuseppe Oliveto, Piergiorgio Roberto, et al.
Biomedicines
|
March 25, 2022
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity
Carmine Rocca, Ernestina Marianna De Francesco, Teresa Pasqua, et al.
Experimental Hematology & Oncology
|
August 6, 2024
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients
Emilia Gigliotta, Federica Plano, Giusy Corsale, et al.
European Journal of Haematology
|
February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
Giulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Drug Design, Development and Therapy
|
July 15, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
Page
of 32
Search research articles
Search
Showing results (141-150 of 313) with videos related to
Sort By:
Page
of 32
European Journal of Haematology
|
July 9, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Microorganisms
|
January 6, 2021
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients
Camilla Bitossi, Federica Frasca, Agnese Viscido, et al.
British Journal of Haematology
|
March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology
|
April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Leukemia & Lymphoma
|
August 23, 2008
The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods
Eugenio Lucia, Bruno Martino, Corrado Mammi, et al.
Pathogens (Basel, Switzerland)
|
February 23, 2024
The Epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative Women and Men: A Ten-Year Retrospective Observational Study in Rome (Italy)
Matteo Fracella, Giuseppe Oliveto, Piergiorgio Roberto, et al.
Biomedicines
|
March 25, 2022
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity
Carmine Rocca, Ernestina Marianna De Francesco, Teresa Pasqua, et al.
Experimental Hematology & Oncology
|
August 6, 2024
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients
Emilia Gigliotta, Federica Plano, Giusy Corsale, et al.
European Journal of Haematology
|
February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
Giulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Drug Design, Development and Therapy
|
July 15, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
Page
of 32